Targeted Medical Pharma, Inc. (TMP), also doing business as Physician Therapeutics (PTL), is a specialty pharmaceutical company that develops and commercializes amino acid-based medications. The Company develops and distributes a line of amino acid-based medical food products, dietary supplements and generic drugs to physicians, pharmacies and patients throughout the United States and abroad. The Company operates through TMP, Complete Claims Processing Inc. (CCPI) and Amino Nutritionals segments. TMP develops and distributes amino acid-based therapeutic products and distributes pharmaceutical products from other manufacturers. CCPI segment provides point-of-care dispensing solutions, and billing and collections services. Amino Nutritionals segment develops and distributes amino acid-based dietary supplements directly to consumers. Its products and services include Medical Foods, Medical foods and generic pharmaceuticals, and Billing and Collections.
Industry, Sector and Symbol:
- 52 Week Range: $0.01 - $0.03
Sales & Book Value:
- Trailing P/E Ratio:
- Foreward P/E Ratio: -0.38
- P/E Growth:
- Annual Revenue: $5.26 million
- Price / Sales: 0.09
- Book Value: ($0.47) per share
- Price / Book: -0.03
- Average Volume: 2,995 shs.
- Beta: -1.88
Frequently Asked Questions for Targeted Medical Pharma (OTCMKTS:TRGM)
What is Targeted Medical Pharma's stock symbol?
Targeted Medical Pharma trades on the OTCMKTS under the ticker symbol "TRGM."
Who are some of Targeted Medical Pharma's key competitors?
Some companies that are related to Targeted Medical Pharma include Johnson & Johnson (JNJ), Roche Holding (RHHBY), Novartis AG (NVS), Pfizer (PFE), Merck & Co. (MRK), UnitedHealth Group (UNH), Sanofi SA (SNY), Medtronic plc. (MDT), Amgen (AMGN), Bayer AG (BAYRY), AbbVie (ABBV), Novo Nordisk A/S (NVO), GlaxoSmithKline plc (GSK), Celgene (CELG), Bristol-Myers Squibb Co (BMY), AstraZeneca plc (AZN), Gilead Sciences (GILD) and Eli Lilly and Co (LLY).
How do I buy Targeted Medical Pharma stock?
Shares of Targeted Medical Pharma can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Targeted Medical Pharma stock cost?
One share of Targeted Medical Pharma stock can currently be purchased for approximately $0.02.
Consensus Ratings for Targeted Medical Pharma (OTCMKTS:TRGM) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Targeted Medical Pharma (OTCMKTS:TRGM)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Targeted Medical Pharma (OTCMKTS:TRGM)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Targeted Medical Pharma (OTCMKTS:TRGM)
Current Year EPS Consensus Estimate: $-0.110 EPS
Next Year EPS Consensus Estimate: $-0.040 EPS
Dividend History for Targeted Medical Pharma (OTCMKTS:TRGM)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Targeted Medical Pharma (OTCMKTS:TRGM)
Insider Ownership Percentage: 69.20%Insider Trades by Quarter for Targeted Medical Pharma (OTCMKTS:TRGM)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/24/2015||Kim Giffoni||CEO||Sell||8,580||$0.02||$171.60|| |
|5/28/2014||William Shell||CEO||Sell||2,000||$0.60||$1,200.00|| |
|5/27/2014||William Shell||CEO||Sell||3,000||$0.65||$1,950.00|| |
|4/10/2014||William Shell||CEO||Sell||150,000||$0.60||$90,000.00|| |
|4/9/2014||Kim Giffoni||EVP||Buy||5,000||$0.83||$4,150.00|| |
|12/12/2013||Kim Giffoni||EVP||Buy||1,000||$0.90||$900.00|| |
|12/11/2013||Kim Giffoni||EVP||Buy||11,980||$0.88||$10,542.40|| |
|12/2/2013||Kim Giffoni||EVP||Buy||4,800||$1.06||$5,088.00|| |
|9/13/2013||William Shell||Director||Sell||2,000||$0.84||$1,680.00|| |
|6/20/2013||William Shell||Director||Buy||28,100||$1.15||$32,315.00|| |
Headline Trends for Targeted Medical Pharma (OTCMKTS:TRGM)
Latest Headlines for Targeted Medical Pharma (OTCMKTS:TRGM)
|Targeted Medical Pharma Finalizes Exclusive Agreement for Distribution in China|
au.finance.yahoo.com - January 13 at 1:00 PM
|TARGETED MEDICAL PHARMA, INC. Financials|
finance.yahoo.com - December 8 at 1:18 PM
|Targeted Medical Pharma Breaks Ground in the Consumer Goods Market|
finance.yahoo.com - December 3 at 1:00 PM
|TARGETED MEDICAL PHARMA, INC. Files SEC form 10-Q, Quarterly Report|
biz.yahoo.com - November 13 at 5:19 PM
|TARGETED MEDICAL PHARMA, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements|
biz.yahoo.com - October 1 at 3:14 PM
|New Research from Targeted Medical Pharma Finds a Link Between Obesity and Nutritional Deficiencies|
finance.yahoo.com - April 27 at 3:00 PM
|TARGETED MEDICAL PHARMA, INC. Files SEC form 10-K, Annual Report|
biz.yahoo.com - April 15 at 6:07 AM
|Tauriga Sciences, Inc. Expands Agreement with Targeted Medical Pharma, Inc.|
finance.yahoo.com - March 4 at 7:45 AM
|TARGETED MEDICAL PHARMA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and|
biz.yahoo.com - March 3 at 4:06 PM
|TARGETED MEDICAL PHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Fi|
biz.yahoo.com - February 27 at 6:42 PM
|Targeted Medical Pharma Announces New Partnership for Exclusive Distribution in Japan|
au.finance.yahoo.com - February 19 at 1:00 PM
Targeted Medical Pharma (TRGM) Chart for Friday, May, 26, 2017